Bristol Advisors’s Eli Lilly LLY Stock Holding History

Bristol Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,700	Closed	-$228K	–	64
2017 Q4	$228K	Buy	+2,700	New	+$230K	0.14%	68

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bristol Advisors's LLY Position: Q1 2018 in Review

Bristol Advisors sold out of Eli Lilly (LLY) in Q1 2018, closing a stake of 2,700 shares — an estimated $228K sold.

Bristol Advisors first reported a position in LLY in Q4 2017 and held it in 1 quarter. The position peaked at $228K in Q4 2017. 1,334 funds tracked by Wall St. Rank hold LLY as of Q1 2018.

Bristol Advisors reported no remaining Eli Lilly position as of Q1 2018 after selling out during the quarter.
Bristol Advisors sold 2,700 Eli Lilly shares in Q1 2018, an estimated $228K.
Bristol Advisors first reported a position in Eli Lilly in Q4 2017 and held it in 1 quarter.
Bristol Advisors's Eli Lilly position peaked at $228K in Q4 2017.
1,334 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2018.

Based on Bristol Advisors's 13F filing for Q1 2018, filed 1 May 2018.